And three, they have an oral version of their GLP1 that unlike the Novo Nordic oral doesn't have what's called the food effect where you don't have to fast before you take it
Avoid direct skin contact, and dispose of needles in a sharps container
this peptide resulted in weight loss and had lipid-lowering and glucose-lowering effects in mice with diet-induced obesity, which were superior to the effects seen with a GLP-1 receptor-selective agonist [77]
As a cardiologist to me, this is by far the most important finding of this study
While most side effects are manageable and temporary, there are more serious risks to be aware of: Pancreatitis Though rare, this condition can be serious
The most commonly reported adverse events in the Phase 2 trial were gastrointestinal in nature, including nausea, vomiting, and diarrhoea consistent with the GLP-1 receptor agonist class